Clinical Trial
Treatment with Antiviral Therapies for Chronic Hepatitis C
Study Description
“HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network”
The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.
Location
Methods
No pharmaceutical medication involved
Recruiting patients only
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
Additional Information
Official Study Title
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Clinical Trial ID
NCT01474811
ParticipAid ID
QeZY6d
